Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(26 sites)

United States

City of Hope, Arcadia, California

Yale Cancer Center, New Haven, Connecticut

Georgetown University, Washington D.C., District of Columbia

Digestive & Liver Center of Florida, Orlando, Florida

Cleveland Clinic Florida, Weston, Florida

University of Chicago, Chicago, Illinois

University of Kansas Medical Center, Kansas City, Kansas

Johns Hopkins University, Baltimore, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

University of Michigan, Ann Arbor, Michigan

Department of Surgery, Section of Colon Rectal and Surgery, St Louis, Missouri

Cleveland Clinic, Cleveland, Ohio

Ohio State University, Columbus, Ohio

Geisinger Medical Center, Danville, Pennsylvania

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

The University of Texas MD Anderson Cancer Center, Houston, Texas

Benaroya Research Institute at Virginia Mason, Seattle, Washington

University of Washington - Fred Hutchinson, Seattle, Washington

Denmark

Copenhagen University Hospital, Copenhagen

Germany

Universitätsklinikum Bonn, Bonn

Netherlands

Amsterdam UMC, Amsterdam

Radboud University Medical Center, Nijmegen

Puerto Rico

Hospital Oncologico - Puerto Rico Medical Center, Rio Piedras

Spain

Hospital Clínic de Barcelona, Barcelona

Hospital Comarcal de Inca, Inca

Hospital La Fe de Valencia, Valencia